Select your country or region to view content specific to your country.
Seeplex® H. pylori-ClaR ACE Detection simultaneously detects and identifies two types of point mutations (A2143G and A2142G) causing clarithromycin-resistance in Helicobacter pylori from direct examination of gastric biopsy tissue without going through bacterial culture. Based on DPO™ technology, this assays performs on PCR instruments and applicable for Auto-capillary Electrophoresis instruments.
Simultaneous identification of H. pylori and two point mutations (A2143G & A2142G), which cause clarithromycin resistance without culture
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
Multiplex PCR with high sensitivity and specificity by utilization of DPO™ technologies
A single round PCR process and 8-MOP reduces the carryover contamination risk
|2||H. pylori, A2143G|
|4||H. pylori, A2143G|
|5||H. pylori, A2142G|
|6||H. pylori, A2143G|
|7||H. pylori, A2142G|
1~8: Clinical samples